BMRN
BioMarin Pharmaceutical Inc.Stock · Health Care$68.50−$1.74 (-2.48%)as of market close, Aug 13, 2026
☾ After hours:$68.53+0.00%3:59 PM ET
BMRN — BioMarin Pharmaceutical Inc. stock price, chart and key statistics
Key stats#
Price data
- Price
- $68.50
- Change YTD
- +15.26%
- Market cap
- 13.3B
- Enterprise value
- 16.6B
- Shares outstanding
- 193.6M
- 52W low
- $49.26
- 52W high
- $70.98
- From 52W high
- -3.49%
- From 52W low
- +39.06%
- 52W range
- 89%
- Beta
- 0.23
Volume
- Rel volume
- 0.87×
- 30D volume
- 2M
- 30D $ vol
- 123.6M
Fundamentals
- Sales (ttm)
- 3.4B
- Sales/share
- $17.60
- EPS (ttm)
- $0.37
- FCF (ttm)
- 738.2M
- FCF/share
- $3.81
- Book value/share
- $32.66
- Net margin
- 2.14%
- ROE
- 1.15%
- ROA
- 0.62%
- Debt / equity
- 0.56×
- Current ratio
- 2.39
Growth (CAGR, ttm) · 10Y
- Sales
- +13.34%
- Net income
- n/a
- FCF
- n/a
- Shares
- +1.71%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- n/a
- Sales/share
- +11.44%
- FCF/share
- n/a
- Book value/share
- +10.78%
- Price
- -2.95%
- Total return
- -2.95%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- 183.8×
- 88.8×
- Fwd P/E
- 9.8×
- 3.9×
- 2.1×
- 18.0×
- EV/EBITDA (fy)
- 55.0×
- EV/Sales (ttm)
- 4.9×
- 5.57%
- -0.81%
- -0.81%
- 0.00%
- 0.00%
Vs own 10Y history
- P/E
- 78th
- P/OI
- 50th
- P/S
- 13th
- P/B
- 14th
- P/FCF
- 22nd
Bar = where today's multiple sits in BMRN's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return#
1D
-2.48%
1W
+11.45%
1M
+16.20%
3M
+27.92%
YTD
+15.26%
1Y
+20.47%
5Y
-12.10%
Financial statements
Open full BMRN financials →Related Health Care#
1MBioMarin Pharmaceutical Inc. (BMRN) trades at $68.50 with a live price and an interactive chart covering 27+ years of daily price history, plus key valuation metrics. ChartRow also publishes BMRN's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full BMRN financial statements →
